The disclosure relates to a medication dispenser, and more particularly to a medical inhaler.
A conventional medication dispenser includes a mouthpiece, a conveying strip that has a plurality of capsules each containing a dose of medication, and a lever that is associated with the conveying strip. Upon operation of the lever, the capsules are aligned with the mouthpiece one at a time, so a user is able to inhale the dose in an aligned one of the capsules via the mouthpiece.
The object of the disclosure is to provide a medication dispenser that can switch between an idle/standby state and an operating state.
According to the disclosure, the medication dispenser includes a base seat, a circuitry unit and an outer casing. The base seat includes a mouthpiece. The circuitry unit is disposed on the base seat, and includes a first circuit board, a battery, a first switch that is disposed on the first circuit board, and a second switch that is disposed on the first circuit board. The outer casing is movably mounted to the base seat, and is movable relative to the base seat between a close position where the outer casing covers the mouthpiece, and an open position where the outer casing uncovers the mouthpiece. When the outer casing is at the close position, the first switch is actuated such that electric power is prevented from being supplied from the battery to the first circuit board. When the outer casing is at the open position, the second switch is actuated such that electric power is supplied from the battery to the first circuit board.
Other features and advantages of the disclosure will become apparent in the following detailed description of the embodiments with reference to the accompanying drawings, of which:
Before the disclosure is described in greater detail, it should be noted that where considered appropriate, reference numerals or terminal portions of reference numerals have been repeated among the figures to indicate corresponding or analogous elements, which may optionally have similar characteristics.
Referring to
Referring to
The base seat 2 includes a seat body 21, and a mouthpiece 23 that is mounted to the seat body 21. The seat body 21 has a top wall 210. The top wall 210 has a main wall portion 211, and a protruding wall portion 212 that protrudes upwardly from the main wall portion 211. The main wall portion 211 of the top wall 210 is formed with a plurality of spaced-apart intake channels 213, and an arc-shaped communicating channel 214 that is in fluid communication with the intake channels 213. The seat body 21 defines a retaining space 216 that is for retaining the dispensing device 3, an inlet path 215 that is in fluid communication with an end of the communicating channel 214 and the retaining space 216, and an outlet path 217 that is in fluid communication with the retaining space 216 and that is located below the inlet path 215. The mouthpiece 23 covers the inlet path 215 and the outlet path 217, and is for contact with the patient's lips.
The dispensing device 3 includes a conveying strip 31, a notched wheel 32, a wrapping wheel 33, a peeler 34 and an operating member 35. The conveying strip 31 includes a base sheet 311 and a lid sheet 312. The base sheet 311 of the conveying strip 31 is elongated and has a longitudinal end connected to a post 218 of the seat body 21. The base sheet 311 extends around the notched wheel 32, and has a plurality of spaced-apart capsules 313 each of which contains a dose of powdered medication. The lid sheet 312 of the conveying strip 31 is elongated, and is for sealing the capsules 313. A portion of the lid sheet 312 is separated from the base sheet 311, and is wound around the wrapping wheel 33. The notched wheel 32 is rotatably mounted to the seat body 21, and has a plurality of equidistantly and angularly spaced-apart notches 321 that are formed in an outer surrounding surface thereof. Each of the notches 321 is for receiving one of the capsules 313 therein, so that the conveying strip 31 meshes with the notched wheel 32. The wrapping wheel 33 is rotatably mounted to the seat body 21, and wraps the portion of the lid sheet 312 that is separated from the base sheet 311.
The wrapping wheel 33 and the notched wheel 32 are associated with each other by two gears (not shown) that are respectively connected to the wrapping wheel 33 and the notched wheel 32 and that mesh with each other. The peeler 34 is disposed between the notched wheel 32 and the wrapping wheel 33, and is for separating the lid sheet 312 from the base sheet 311. The operating member 35 has a major portion mounted in the receiving space 216. The operating member 35 is associated with the notched wheel 32 by virtue of a one-way transmission mechanism (not shown), and has a lever portion 351 that projects out of the seat body 21. Upon depression of the lever portion 351, the operating member 35 drives the notched wheel 32 to rotate by a predetermined angle via the one-way transmission mechanism, so that one of the capsules 313 of the conveying strip 31 is driven to be aligned with and in fluid communication with the inlet path 215 and the outlet path 217, so as to permit the patient to inhale the dose therein via the mouthpiece 23. At the same time, the peeler 34 partially separates the lid sheet 312 from the base sheet 311, and the wrapping wheel 33 is driven by the notched wheel 32 to wrap the separated portion of the lid sheet 312. In this embodiment, the intake channels 213 cooperate with the communicating channel 214, the inlet path 215, the notch 321 of the notched wheel 32 that is aligned with the inlet path 215, and the outlet path 217 to define a flow path (P, see
Referring to
Referring to
The magnets 417 are fixedly mounted to a top surface 322 of the notched wheel 32, and are equidistantly and angularly spaced apart from each other. The number of the notches 321 of the notched wheel 32 is even. The number of the magnets 417 is even, and is half the number of the notches 321. Only one of any two adjacent ones of the notches 321 is radially aligned with a corresponding one of the magnets 417 with respect to a center of the notched wheel 32. In one embodiment, the number of the notches 321 is eight, and the number of the magnets 417 is four. The notched wheel 32 is rotated by 360 degrees by depressing the lever portion 351 of the operating member 35 eight times.
Referring to
Referring to
In one embodiment, the seal member 5 is formed with an installation space 51 that is located at an end portion of the communicating channel 214 proximate to the inlet path 215. The pressure sensor 419 is disposed on the bottom surface 413 of the first circuit board 411, and is mounted to the installation space 51 of the seal member 5. Since the pressure sensor 419 is disposed adjacent to the end portion of the communicating channel 214 proximate to the inlet path 215 at which the velocity of air flow is relatively high, the accuracy of the pressure difference determined by the pressure sensor 419 is enhanced. Moreover, since each of the capsules 313 of the conveying strip 31 is located downstream of the pressure sensor 419 during the inhalation of the patient when it is in spatial communication with the inlet path 215 and the outlet path 217, the powdered medication in the capsules 313 does not get in contact with the pressure sensor 419 to thereby prevent break down of the pressure sensor 419.
In one embodiment, the Hagen-Poiseuille law is adopted to determine whether the flow rate of the inhalation of the patient is sufficient to deliver the dose. At least a portion of the communicating channel 214 is assumed to be a uniform straight tube. The airflow is assumed to be a laminar flow and the air is regarded as an incompressible fluid.
Referring to
The environmental sensor 423 detects the humidity and temperature during use, load or transport of the medication dispenser 10. The chip 415 receives the information detected by the environmental sensor 423, and transfers the information about the humidity and temperature to the portable mobile communication device 12 via the first communication network 11. The portable mobile communication device 12 displays the humidity and temperature via an application, and the patient can be informed of the environmental humidity and temperature by the portable mobile communication device 12. When the environmental humidity or temperature of the medication dispenser 10 exceeds a predetermined value, the portable mobile communication device 12 would warn the patient that the medication dispenser 10 is in an unfavorable environmental condition, and that the patient may stop taking the medication in the medication dispenser 10.
The first switch 424 and the second switch 425 are spaced apart from each other. Each of the first and second switches 424, 425 includes a push arm 426. When the push arm 426 of the first switch 424 is actuated, electric power is prevented from being supplied to the first circuit board 411 from the battery 416, so the medication dispenser 10 is switched into an idle/standby state. When the push arm 426 of the second switch 425 is actuated, electric power is supplied to the first circuit board 411 from the battery 416, so the medication dispenser 10 is switched into an operating state.
Referring to
When the patient places the mouthpiece 23 onto his mouth, the infrared proximity sensor 433 first detects the approach of the patient's lips, the capacitive sensor 432 then detects the contact of the patient's lips therewith, and the infrared temperature sensor 434 finally detects the temperature of the patient's lips. Each of the capacitive sensor 432, the infrared proximity sensor 433 and the infrared temperature sensor 434 generates a signal upon detection of the presence of the patient's lips. The chip 415 determines that the patient is using the medication dispenser 10 upon reception of all of the signals generated by the capacitive sensor 432, the infrared proximity sensor 433 and the infrared temperature sensor 434 via the second circuit board 431, the communication sub-unit 435 and the first circuit board 411. By virtue of the capacitive sensor 432, the infrared proximity sensor 433 and the infrared temperature sensor 434, the chip 415 is able to more accurately determine if the patient is using the medication dispenser 10. For example, the medication dispenser 10 is not considered to be in use when the chip 415 receives only one or two of the signals generated by the capacitive sensor 432, the infrared proximity sensor 433 and the infrared temperature sensor 434.
Referring to
The cover plate 61 further has an arc-shaped guide groove 612 that is formed in a top surface of the cover plate 61, and two communication holes 613 that are formed in the bottom surface of the cover plate 61 and that are respectively in spatial communication with two opposite ends of the guide groove 612. The push arm 426 of each of the first and second switches 424, 425 extends into the guide groove 612 via a respective one of the communication holes 613.
Referring to
The operation of the medication dispenser 10 is described as follows:
Referring to
Referring to
When a second end 732 of the side plate 73 of the outer casing 7 abuts against a second flange 228 of the thumb hold portion 226 of the seat body 21 of the base seat 2, the relative rotation between the base seat 2 and the outer casing 7 is stopped, and the outer casing 7 is moved to the open position such that the mouthpiece 23, the intake channels 213 and the lever portion 351 of the operating member 35 are uncovered.
Referring to
Referring to
Referring to
Referring to
Referring to
In one embodiment, the chip 415 transfers the signals generated by the capacitive sensor 432, the infrared proximity sensor 433 or the infrared temperature sensor 434 to the portable mobile communication device 12 upon reception of each of the signals, and the portable mobile communication device 12 determines if the patient is using the medication dispenser 10 according to the signals generated by the capacitive sensor 432, the infrared proximity sensor 433 and the infrared temperature sensor 434.
Referring to
Referring to
Referring to
Referring to
In addition, the medication dispenser 10 may have built-in information of serial number or validity period that are registered in the network computer 14. The serial number enables the certification of the medication dispenser 10 before use, so as to prevent counterfeits. According to the register of the validity period, the medication dispenser 10 can be monitored by the application in the portable mobile communication device 12 to prevent the use after expiration thereof.
The network computer 14 may provide predetermined medication treatments to physicians or pharmacists, and the physicians or the pharmacists can monitor the status of a selected medication treatment of the patient by the monitoring device 15 connected to the network computer 14 so as to monitor medication adherence of the patient. The physicians and the pharmacists may be informed of the number of the remaining doses in the medication dispenser 10 via the monitoring device 15, so as to advise the patient when to reload the medication dispenser 10 via the network computer 14 and the portable mobile communication device 12.
Referring to
In this embodiment, the seat body 21 is made of plastic, the communication sub-unit 435 is configured as a circuit pattern that is directly formed on the main wall portion 211 of the seat body 21 by Laser Selective Plating (LSP). The seat body 21 is first soaked in a water-soluble reactive metal solution, so an active metal layer (i.e., a catalyst metal layer or a seed layer) is formed on the main wall portion 211 of the seat body 21 before the seat body 21 is removed from the solution. Then, the active metal layer is etched by a process of laser etching to form a pattern, and a chemical-plating metal layer is formed on the patterned active metal layer by a process of chemical plating. Afterward, an electroplating metal layer is selectively formed on the chemical-plating metal layer by a process of electroplating. As such, the circuit pattern is formed on the main wall portion 211 of the seat body 21. The communication sub-unit 435 has two opposite ends respectively and electrically coupled to the first circuit board 411 and the second circuit board 431. It should be noted that the abovementioned Laser Selective Plating is just one of various processes for forming a Molded Interconnect Device (MID), and that any process for forming a circuit pattern on a non-metal substrate may be adopted to form the communication sub-unit 435 of the second embodiment.
Referring to
Referring to
The main circuit module 41 further includes an auxiliary battery 428 that is disposed on the top surface 412 of the first circuit board 411. The auxiliary battery 418 is for supplying electrical power to the environmental sensor 423. By such, when the medication dispenser 10 is in the idle/standby state, electric power is kept supplying from the auxiliary battery 428 to the environmental sensor 423, so the environmental sensor 423 continuously detects and records the humidity and temperature for a long term.
Referring to
The base seat 2 of the fourth embodiment is substantially elliptical. The mechanism of the dispensing device (not shown) and the outer cover 7 can be referred to a medical inhaler of GlaxoSmithKline (GSK) named Arnuity Ellipta. The circuitry unit 4 is disposed in the retaining space 216 of the base seat 2. The top wall 210 of the base seat 2 is formed with two communication holes 229 that are in spatial communication with the retaining space 216. The push arm 426 of each of the first and second switches 424, 425 extends through the top wall 210 via a respective one of the communication holes 229. When the outer casing 7 is at a close position (see
In summary, by virtue of the first and second switches 424, 425, the medication dispenser 10 is switched between the idle/standby state and the operating state upon the movement of the outer casing 7 between the close position and the open position.
In the description above, for the purposes of explanation, numerous specific details have been set forth in order to provide a thorough understanding of the embodiments. It will be apparent, however, to one skilled in the art, that one or more other embodiments may be practiced without some of these specific details. It should also be appreciated that reference throughout this specification to “one embodiment,” “an embodiment,” an embodiment with an indication of an ordinal number and so forth means that a particular feature, structure, or characteristic may be included in the practice of the disclosure. It should be further appreciated that in the description, various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of various inventive aspects.
While the disclosure has been described in connection with what are considered the exemplary embodiments, it is understood that this disclosure is not limited to the disclosed embodiments but is intended to cover various arrangements included within the spirit and scope of the broadest interpretation so as to encompass all such modifications and equivalent arrangements.
Number | Date | Country | Kind |
---|---|---|---|
201610876992.3 | Oct 2016 | CN | national |
This application is a continuation application (CA) of co-pending U.S. patent application Ser. No. 15/722,713, filed on Oct. 2, 2017, which claims priority of Chinese Patent Application No. 201610876992.3, filed on Oct. 3, 2016, which are both incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3092576 | Daubman | Jun 1963 | A |
5020527 | Dessertine | Jun 1991 | A |
5207217 | Cocozza et al. | May 1993 | A |
5450054 | Schmersal | Sep 1995 | A |
5860419 | Davies | Jan 1999 | A |
5873360 | Davies | Feb 1999 | A |
6012454 | Hodson et al. | Jan 2000 | A |
6026809 | Abrams et al. | Feb 2000 | A |
6029659 | O'Connor | Feb 2000 | A |
6104592 | Pohl | Aug 2000 | A |
6234167 | Cox et al. | May 2001 | B1 |
6684880 | Trueba | Feb 2004 | B2 |
6971383 | Hickey et al. | Dec 2005 | B2 |
7198044 | Trueba | Apr 2007 | B2 |
7249687 | Anderson | Jul 2007 | B2 |
7434579 | Young et al. | Oct 2008 | B2 |
7896192 | Conley | Mar 2011 | B2 |
7950389 | Eason et al. | May 2011 | B2 |
8584673 | Thoemmes et al. | Nov 2013 | B2 |
8967508 | Kindelan | Mar 2015 | B2 |
9636471 | Anderson et al. | May 2017 | B2 |
9980880 | Litton | May 2018 | B1 |
10300227 | Sutherland et al. | May 2019 | B2 |
10369305 | Li | Aug 2019 | B2 |
10528074 | Olsson | Jan 2020 | B1 |
20020053344 | Davies et al. | May 2002 | A1 |
20020066451 | Davies et al. | Jun 2002 | A1 |
20040025877 | Crowder et al. | Feb 2004 | A1 |
20070062525 | Bonney | Mar 2007 | A1 |
20070199951 | Levasseur | Aug 2007 | A1 |
20070215149 | King et al. | Sep 2007 | A1 |
20080054745 | Sentmanat | Mar 2008 | A1 |
20080193617 | Sus | Aug 2008 | A1 |
20090315306 | Worrell et al. | Dec 2009 | A1 |
20100137802 | Yodfat | Jun 2010 | A1 |
20110025437 | Preaux | Feb 2011 | A1 |
20110041845 | Solomon | Feb 2011 | A1 |
20110232584 | Valencia | Sep 2011 | A1 |
20120037157 | Rohrschneider et al. | Feb 2012 | A1 |
20130153696 | Kindelan | Jun 2013 | A1 |
20130310729 | White | Nov 2013 | A1 |
20140158704 | Anderson et al. | Jun 2014 | A1 |
20150027286 | Yuyama | Jan 2015 | A1 |
20150338445 | White | Nov 2015 | A1 |
20160107820 | Macvittie | Apr 2016 | A1 |
20170239415 | Hwang | Aug 2017 | A1 |
20170264991 | Horst | Sep 2017 | A1 |
20180296767 | Sall | Oct 2018 | A1 |
20180335159 | Rogers | Nov 2018 | A1 |
20190022339 | Richardson | Jan 2019 | A1 |
20190201293 | Brady | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
1668354 | Sep 2005 | CN |
204043730 | Dec 2014 | CN |
9949920 | Oct 1999 | WO |
0303515 | May 2003 | WO |
03090825 | Nov 2003 | WO |
03092576 | Nov 2003 | WO |
2005009325 | Feb 2005 | WO |
2005080001 | Sep 2005 | WO |
2011129791 | Oct 2011 | WO |
2011129793 | Oct 2011 | WO |
2017037161 | Mar 2017 | WO |
Entry |
---|
Search Report appended to an Office Action issued to Chinese counterpart application No. 201610876992.3 by the CNIPA dated Mar. 11, 2020, with an English translation thereof. |
Search Report appended to an Office Action, which was issued to Chinese counterpart application No. 201811141317.1 by the CNIPA dated Feb. 26, 2021 with an English translation thereof. |
Number | Date | Country | |
---|---|---|---|
20190298946 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15722713 | Oct 2017 | US |
Child | 16445833 | US |